Wei Yin

853 total citations · 1 hit paper
22 papers, 651 citations indexed

About

Wei Yin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Wei Yin has authored 22 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Wei Yin's work include Animal Virus Infections Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Viral gastroenteritis research and epidemiology (3 papers). Wei Yin is often cited by papers focused on Animal Virus Infections Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Viral gastroenteritis research and epidemiology (3 papers). Wei Yin collaborates with scholars based in China, United States and United Kingdom. Wei Yin's co-authors include Jason A. Ngo, Dario Marchetti, Michael D. Wetzel, Morris D. Groves, Lixin Zhang, Lon D. Ridgway, Disha Kumar, J. Clay Goodman, Jianhua Guo and Yaogui Sun and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Wei Yin

20 papers receiving 648 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis

2013 412 citations Lixin Zhang, Lon D. Ridgway et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei Yin China	11	430	274	213	169	119	22	651
Zhenzhen Xu China	13	215 0.5×	181 0.7×	268 1.3×	72 0.4×	58 0.5×	28	575
Tze‐Sian Chan Taiwan	11	276 0.6×	171 0.6×	377 1.8×	91 0.5×	26 0.2×	22	627
Min Pan China	12	213 0.5×	153 0.6×	334 1.6×	61 0.4×	65 0.5×	35	613
Jonas J. Staudacher United States	11	321 0.7×	153 0.6×	359 1.7×	94 0.6×	40 0.3×	25	693
Kunitoshi Shigeyasu Japan	16	202 0.5×	308 1.1×	649 3.0×	119 0.7×	48 0.4×	67	951
Xueqing Yao China	13	210 0.5×	230 0.8×	360 1.7×	103 0.6×	31 0.3×	51	635
Franziska Arlt Germany	7	301 0.7×	236 0.9×	519 2.4×	115 0.7×	22 0.2×	7	848
Timo Hillebrand Germany	11	384 0.9×	151 0.6×	284 1.3×	91 0.5×	31 0.3×	16	651
He Dou China	5	218 0.5×	207 0.8×	302 1.4×	99 0.6×	99 0.8×	10	646

Countries citing papers authored by Wei Yin

Since Specialization

Citations

This map shows the geographic impact of Wei Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Yin more than expected).

Fields of papers citing papers by Wei Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Yin. The network helps show where Wei Yin may publish in the future.

Co-authorship network of co-authors of Wei Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Yin. A scholar is included among the top collaborators of Wei Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Yin. Wei Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yin, Wei, Zhi‐Gang Qian, Chun Liu, Bong Keun Song, & Qi‐Shun Sun. (2025). Autologous serum supplementation promotes the phenotype maintenance of human chondrocytes with increased cellular autophagy. Scientific Reports. 15(1). 8319–8319.

Wang, Hong, Na Sun, Panpan Sun, et al.. (2024). Matrine regulates autophagy in ileal epithelial cells in a porcine circovirus type 2-infected murine model. Frontiers in Microbiology. 15. 1455049–1455049.

Sun, Panpan, Ajab Khan, Jianhua Guo, et al.. (2023). Matrine combined with Osthole inhibited the PERK apoptosis of splenic lymphocytes in PCV2-infected mice model. BMC Veterinary Research. 19(1). 26–26. 10 indexed citations

Zhang, Hua, Panpan Sun, Yaogui Sun, et al.. (2023). Network pharmacology and experimental validation to reveal the target of matrine against PRRSV. iScience. 26(4). 106371–106371. 6 indexed citations

Wang, Xinyu, Zheng Xu, Yangang Liu, et al.. (2023). Safety and efficacy of lentinan nasal drops in patients infected with the variant of COVID-19: a randomized, placebo-controlled trial. Frontiers in Pharmacology. 14. 1292479–1292479. 2 indexed citations

Yin, Wei, Ming Guo, Zhenya Tang, et al.. (2022). MET Expression Level in Lung Adenocarcinoma Loosely Correlates with MET Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome. Cancers. 14(10). 2433–2433. 10 indexed citations

Fan, Kuohai, et al.. (2021). Truncated Diphtheria Toxin DT390 Enhances the Humoral Immunogenicity of Porcine Circovirus Type 2 Capsid Antigen in Mice. Viral Immunology. 34(7). 448–456. 1 indexed citations

Yin, Wei, et al.. (2021). Synergistic effects of autophagy inhibitors combined with cisplatin against cisplatin-resistant nasopharyngeal cancer cells. Biochemistry and Cell Biology. 99(3). 322–329. 2 indexed citations

Yin, Wei, Zhenya Tang, Gökçe Törüner, et al.. (2020). MET Amplification (MET/CEP7 Ratio ≥ 1.8) Is an Independent Poor Prognostic Marker in Patients With Treatment-naive Non–Small-cell Lung Cancer. Clinical Lung Cancer. 22(4). e512–e518. 13 indexed citations

10.

Yin, Wei, Wei Liu, Ming Guo, et al.. (2020). Acquired MET amplification in non-small cell lung cancer is highly associated with the exposure of EGFR inhibitors and may not affect patients' outcome. Experimental and Molecular Pathology. 118. 104572–104572. 3 indexed citations

11.

Sun, Na, Hua Zhang, Panpan Sun, et al.. (2020). Matrine exhibits antiviral activity in a PRRSV/PCV2 co-infected mouse model. Phytomedicine. 77. 153289–153289. 37 indexed citations

12.

Vishnoi, Monika, Debasish Boral, Haowen Liu, et al.. (2018). Targeting USP7 Identifies a Metastasis-Competent State within Bone Marrow–Resident Melanoma CTCs. Cancer Research. 78(18). 5349–5362. 36 indexed citations

13.

Lim, Wan‐Teck, Myung‐Ju Ahn, Quan‐Sing Ng, et al.. (2018). Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC. Clinical Pharmacology in Drug Development. 7(5). 532–542. 15 indexed citations

14.

Tyulyandina, Alexandra, Wei Yin, Е. В. Степанова, et al.. (2016). Alofanib, an allosteric FGFR2 inhibitor, has potent effects on ovarian cancer growth in preclinical studies. Investigational New Drugs. 35(2). 127–133. 20 indexed citations

15.

He, Xuelian, Wei Yin, Yan Ding, et al.. (2015). Higher Serum Angiotensinogen Is an Indicator of IgA Vasculitis with Nephritis Revealed by Comparative Proteomes Analysis. PLoS ONE. 10(6). e0130536–e0130536. 14 indexed citations

16.

Yin, Wei, et al.. (2015). Differentially Expressed Genes in EEC and LMS Syndromes. PLoS ONE. 10(6). e0129432–e0129432. 4 indexed citations

17.

Tabernero, Josep, María Elena Elez, María Herranz‐López, et al.. (2014). A Pharmacodynamic/Pharmacokinetic Study of Ficlatuzumab in Patients with Advanced Solid Tumors and Liver Metastases. Clinical Cancer Research. 20(10). 2793–2804. 30 indexed citations

18.

Zhang, Lixin, Lon D. Ridgway, Michael D. Wetzel, et al.. (2013). The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis. Science Translational Medicine. 5(180). 180ra48–180ra48. 412 indexed citations breakdown →

19.

He, Xuelian, et al.. (2012). C1GALT1 polymorphisms are associated with Henoch–Schönlein purpura nephritis. Pediatric Nephrology. 27(9). 1505–1509. 16 indexed citations

20.

Liu, Yi, et al.. (2011). Preventive effect of Ibrolipim on suppressing lipid accumulation and increasing lipoprotein lipase in the kidneys of diet-induced diabetic minipigs. Lipids in Health and Disease. 10(1). 117–117. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact